Obesity Not Associated With Worse Long-Term TAR Outcomes
-
By
-
Kathryn Wighton
-
May 6, 2026
-
4 min
By
Kathryn Wighton
May 6, 2026
Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.
June 12, 2026